396 related articles for article (PubMed ID: 30520725)
1. A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV.
OhAinle M; Helms L; Vermeire J; Roesch F; Humes D; Basom R; Delrow JJ; Overbaugh J; Emerman M
Elife; 2018 Dec; 7():. PubMed ID: 30520725
[TBL] [Abstract][Full Text] [Related]
2. Immunoproteasome activation enables human TRIM5α restriction of HIV-1.
Jimenez-Guardeño JM; Apolonia L; Betancor G; Malim MH
Nat Microbiol; 2019 Jun; 4(6):933-940. PubMed ID: 30886358
[TBL] [Abstract][Full Text] [Related]
3. Editing of the TRIM5 Gene Decreases the Permissiveness of Human T Lymphocytic Cells to HIV-1.
Désaulniers K; Ortiz L; Dufour C; Claudel A; Plourde MB; Merindol N; Berthoux L
Viruses; 2020 Dec; 13(1):. PubMed ID: 33375604
[TBL] [Abstract][Full Text] [Related]
4. Identification of Interferon-Stimulated Gene Proteins That Inhibit Human Parainfluenza Virus Type 3.
Rabbani MA; Ribaudo M; Guo JT; Barik S
J Virol; 2016 Dec; 90(24):11145-11156. PubMed ID: 27707917
[TBL] [Abstract][Full Text] [Related]
5. The Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor Usage.
Yu J; Liu SL
Viruses; 2018 Aug; 10(8):. PubMed ID: 30087232
[TBL] [Abstract][Full Text] [Related]
6. TLR-4 engagement of dendritic cells confers a BST-2/tetherin-mediated restriction of HIV-1 infection to CD4+ T cells across the virological synapse.
Blanchet FP; Stalder R; Czubala M; Lehmann M; Rio L; Mangeat B; Piguet V
Retrovirology; 2013 Jan; 10():6. PubMed ID: 23311681
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 with gag processing defects activates cGAS sensing.
Sumner RP; Blest H; Lin M; Maluquer de Motes C; Towers GJ
Retrovirology; 2024 May; 21(1):10. PubMed ID: 38778414
[TBL] [Abstract][Full Text] [Related]
8. Functional landscape of SARS-CoV-2 cellular restriction.
Martin-Sancho L; Lewinski MK; Pache L; Stoneham CA; Yin X; Becker ME; Pratt D; Churas C; Rosenthal SB; Liu S; Weston S; De Jesus PD; O'Neill AM; Gounder AP; Nguyen C; Pu Y; Curry HM; Oom AL; Miorin L; Rodriguez-Frandsen A; Zheng F; Wu C; Xiong Y; Urbanowski M; Shaw ML; Chang MW; Benner C; Hope TJ; Frieman MB; García-Sastre A; Ideker T; Hultquist JF; Guatelli J; Chanda SK
Mol Cell; 2021 Jun; 81(12):2656-2668.e8. PubMed ID: 33930332
[TBL] [Abstract][Full Text] [Related]
9. Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages.
Ma TC; Zhou RH; Wang X; Li JL; Sang M; Zhou L; Zhuang K; Hou W; Guo DY; Ho WZ
Sci Rep; 2016 Oct; 6():34752. PubMed ID: 27734899
[TBL] [Abstract][Full Text] [Related]
10. In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha.
Ashokkumar M; Sonawane A; Sperk M; Tripathy SP; Neogi U; Hanna LE
Sci Rep; 2020 Feb; 10(1):2747. PubMed ID: 32066770
[TBL] [Abstract][Full Text] [Related]
11. Role of MxB in Alpha Interferon-Mediated Inhibition of HIV-1 Infection.
Xu B; Pan Q; Liang C
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925663
[TBL] [Abstract][Full Text] [Related]
12. Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid.
Sultana T; Mamede JI; Saito A; Ode H; Nohata K; Cohen R; Nakayama EE; Iwatani Y; Yamashita M; Hope TJ; Shioda T
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511380
[TBL] [Abstract][Full Text] [Related]
13. TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment.
Singh R; Patel V; Mureithi MW; Naranbhai V; Ramsuran D; Tulsi S; Hiramen K; Werner L; Mlisana K; Altfeld M; Luban J; Kasprowicz V; Dheda K; Abdool Karim SS; Ndung'u T
J Virol; 2014 Apr; 88(8):4291-303. PubMed ID: 24478420
[TBL] [Abstract][Full Text] [Related]
14. Disrupting HIV-1 capsid formation causes cGAS sensing of viral DNA.
Sumner RP; Harrison L; Touizer E; Peacock TP; Spencer M; Zuliani-Alvarez L; Towers GJ
EMBO J; 2020 Oct; 39(20):e103958. PubMed ID: 32852081
[TBL] [Abstract][Full Text] [Related]
15. The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.
Yan R; Zhao X; Cai D; Liu Y; Block TM; Guo JT; Guo H
J Virol; 2015 Sep; 89(18):9200-12. PubMed ID: 26109732
[TBL] [Abstract][Full Text] [Related]
16. [Protection of Lymphocytes Against HIV using Lentivirus Vector Carrying a Combination of TRIM5α-HRH Genes and microRNA Against CCR5].
Omelchenko DO; Glazkova DV; Bogoslovskaya EV; Urusov FA; Zhogina YA; Tsyganova GM; Shipulin GA
Mol Biol (Mosk); 2018; 52(2):294-305. PubMed ID: 29695698
[TBL] [Abstract][Full Text] [Related]
17. Lentiviral gene therapy against human immunodeficiency virus type 1, using a novel human TRIM21-cyclophilin A restriction factor.
Chan E; Schaller T; Eddaoudi A; Zhan H; Tan CP; Jacobsen M; Thrasher AJ; Towers GJ; Qasim W
Hum Gene Ther; 2012 Nov; 23(11):1176-85. PubMed ID: 22909012
[TBL] [Abstract][Full Text] [Related]
18. HIV Restriction Factors and Mechanisms of Evasion.
Malim MH; Bieniasz PD
Cold Spring Harb Perspect Med; 2012 May; 2(5):a006940. PubMed ID: 22553496
[TBL] [Abstract][Full Text] [Related]
19. Efficient Transduction of Human and Rhesus Macaque Primary T Cells by a Modified Human Immunodeficiency Virus Type 1-Based Lentiviral Vector.
He H; Xue J; Wang W; Liu L; Ye C; Cong Z; Kimata JT; Qin C; Zhou P
Hum Gene Ther; 2017 Mar; 28(3):271-285. PubMed ID: 28042947
[TBL] [Abstract][Full Text] [Related]
20. Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo.
Lavender KJ; Gibbert K; Peterson KE; Van Dis E; Francois S; Woods T; Messer RJ; Gawanbacht A; Müller JA; Münch J; Phillips K; Race B; Harper MS; Guo K; Lee EJ; Trilling M; Hengel H; Piehler J; Verheyen J; Wilson CC; Santiago ML; Hasenkrug KJ; Dittmer U
J Virol; 2016 Jul; 90(13):6001-6013. PubMed ID: 27099312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
